The IRS has issued a notice of proposed rulemaking on electronic furnishing of payee statements regarding digital asset sales by brokers. The proposed regulations provide guidance on making an ...

Polymarket failed to convince a federal judge to grant it an emergency reprieve against a potential enforcement lawsuit by Michigan gaming regulators.

Anthropic PBC told a judge it could lose as much as billions of dollars in revenue this year and urged quick action on its request to block the Trump administration’s declaration of the company as a ...

US immigrant hopefuls will need to hold a valid passport from their home country before entering the Diversity Visa lottery ...

New York Democratic lawmakers are seeking to raise income taxes on filers earning at least $5 million, putting increased ...

Kevin Warsh, President Donald Trump’s pick for Federal Reserve chair, failed Tuesday to sway a key Republican senator to drop his confirmation blockade amid the administration’s investigation into the ...

An assistant US attorney in North Carolina said he’s resigning over AI-created fabricated quotes and erroneous citations in an AI-produced court brief.

Real estate developer Glenn Straub and his lawyer created fraudulent operating agreements and meeting minutes to gain an advantage in an ownership fight over the Miss America beauty pageant, a federal ...

The Cincinnati Archdiocese and its Moeller High School are free of a former administrative assistant’s claims she was sexually harassed and assaulted by the school’s former athletic director..

The California Public Utilities Commission followed the law when it composed a new residential solar policy that lowered the compensation for households sending energy to the grid, a California ...

Boston school officials appeared poised Tuesday to escape a challenge to their replacement of merit-based admissions to its elite public schools with criteria that allegedly designed to limit white ...

Cytokinetics Inc. board members sold stock worth $16 million while they kept the public in the dark about a deficiency in the biotech company’s FDA application for a heart drug, an investor alleges.